Images List Premium Download Classic

Analogue

Analogue-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
NEW Acylated glucagon analogues
Novo Nordisk A/s
January 18, 2018 - N°20180016319

The present invention relates to novel peptide compounds which have an improved physical stability in solution and improved solubility at neutral ph, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The compounds of the ...
NEW Morphan and morphinan analogues, and methods of use
Alkermes Pharma Ireland Limited
January 18, 2018 - N°20180016237

The present application relates to analogues of morphan and morphinan, compositions thereof, and methods for treating a disease or condition comprising administering an effective amount of the compounds or compositions to a subject in need thereof.
NEW Therapeutic and prophylactic methods, uses and compositions comprising anexin a5
Annexin Pharmaceuticals Ab
January 18, 2018 - N°20180015142

The present invention provides a method for the prevention and/or reduction of peri- or postoperative complications following surgical intervention, such as complications following vascular surgery, especially peripheral vascular surgery, comprising administering a therapeutically effective amount of annexin a5 or a functional analogue or variant thereof to a patient in need of such treatment. Also provided is a pharmaceutical composition ...
NEW Analogue Patent Pack
Download 338+ patent application PDFs
Analogue Patent Applications
Download 338+ Analogue-related PDFs
For professional research & prior art discovery
inventor
  • 338+ full patent PDF documents of Analogue-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
NEW Design, synthesis and methods of use of acyclic flexmier nucleoside analogues having anti-coronavirus activity
Leiden University Medical Center
January 18, 2018 - N°20180015052

The present invention is directed to compounds, methods and compositions for treating or preventing viral infections using nucleosides analogs. Specifically, the present invention provides for the design and synthesis of acyclic fleximer nucleoside analogues having increased flexibility and ability to alter their conformation structures to provide increased antiviral activity potential with the result of inhibiting several coronaviruses.
Sensor arrangement having an optimized group delay and signal processing method
Infineon Technologies Ag
January 11, 2018 - N°20180014124

In various embodiments, a circuit arrangement is provided. The circuit arrangement includes a sensor set up to provide an analogue signal, an analogue/digital converter set up to receive the analogue signal and to provide a first signal, and a first filter set up to receive a signal based on the first signal and to provide a second signal. The ...
Method and device for providing a trusted environment for executing an analogue-digital signature
Obschestvo S Ogranichennoj Otvetstvennostyu "laboratoria Elandis"
January 11, 2018 - N°20180013563

The invention relates to the field of providing a trusted environment for executing an analogue-digital signature. The claimed document-signing device in the form of a stylus includes a protective compartment, in which the following are disposed: a microcontroller with a programme code; a memory with a secret digital signature key; and additionally inertial sensors, which are connected to the microcontroller; ...
Analogue Patent Pack
Download 338+ patent application PDFs
Analogue Patent Applications
Download 338+ Analogue-related PDFs
For professional research & prior art discovery
inventor
  • 338+ full patent PDF documents of Analogue-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Highly selective anti-cancer agents targeting non-small cell lung cancer and other forms of cancer
The University Of Toledo
January 11, 2018 - N°20180009772

Described herein are analogues of 2-methyl-3-(2-ethynylthiazol-4-yl)cyclopent-2-enol and the corresponding ketone 3-(2-ethynylthiazol-4-yl)-2-methylcyclopent-2-enone, the analogues having terminal alkyne groups at the 2-position of the thiazole ring. These drug-like molecules, referred to as cetzole compounds, are useful to treat non-small cell lung cancer and other forms of cancer. Methods of making and using ...
Therapy for vitiligo
Clinuvel Pharmaceuticals Limited
January 11, 2018 - N°20180008676

The present invention relates to a therapy for vitiligo. In particular the present invention provides a pharmaceutical composition comprising an alpha melanocyte stimulating hormone (alpha-msh) analogue either alone, in combination with narrow band uvb and/or in combination with one or more corticosteroids, immunosuppressants, anti-inflammatory agents and/or photochemotherapeutic agents for the treatment or prevention of vitiligo.
Composition for use in increasing engraftment efficacy of haematopoetic stem cells after transplantation
Scipharm SÀrl
January 11, 2018 - N°20180008606

The present invention provides the new use of composition comprising at least one inhibitor of dipeptidyl peptidase iv (dpp-iv) for increasing migration and homing of haematopoetic progenitor cells in stem cell transplanted recipients, wherein said haematopoetic stem and/or progenitor cells had been treated in vitro with an engraftment enhancing compound, specifically with a prostacyclin analogue and a camp enhancer ...
Method and system for suppressing a parasite signal received by a satellite payload
Airbus Defence And Space Sas
January 04, 2018 - N°20180006673

A method for suppressing a parasite signal received with a useful signal by a network of elementary antennas of a payload of a satellite. The suppression method includes an analogue formation step for forming analog beams and a digital formation step for forming a digital beam. The analog formation step includes forming of an useful analog beam in which the ...
Tetradentate metal complexes containing indoloacridine and its analogues
Airbus Defence And Space Sas
January 04, 2018 - N°20180006246

The complexes are suitable for use as phosphorescent or delayed fluorescent and phosphorescent emitters in display and lighting applications.
Benzocyclooctene-based and indene-based anticancer agents
Baylor University
January 04, 2018 - N°20180002355

Benzocyclooctene (fused 6,8 ring system) analogues and corresponding indene (fused 6,5 ring system) analogues function as inhibitors of tubulin polymerization. The compounds are useful as anticancer agents in a new therapeutic approach for cancer treatment utilizing small-molecule inhibitors of tubulin polymerization that also act as vascular disrupting agents (vdas).
Wound coverings comprising vitamin d and related methods
Marshall University Research Corporation
January 04, 2018 - N°20180000980

A wound covering is provided that comprises a substrate and vitamin d, or analogues or metabolites thereof, embedded in the substrate. Methods of making a wound covering are also provided and include the steps of providing a solution that includes a polymer; adding vitamin d, or analogues or metabolites thereof, to the solution to form a mixture; and forming one ...
Analogue Patent Pack
Download 338+ patent application PDFs
Analogue Patent Applications
Download 338+ Analogue-related PDFs
For professional research & prior art discovery
inventor
  • 338+ full patent PDF documents of Analogue-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Predictive marker for topoisomerase i inhibitors
Boston Medical Center Corporation
December 28, 2017 - N°20170369591

The present invention generally relates to the fields of cancer therapy and cancer prevention. More particularly, the present invention generally relates to a diagnostic marker for predicting the efficacy of topoisomerase i (topo i) inhibitors in the treatment of cancers. More specifically, the present invention relates to methods, machines, computer systems, computable readable media and kits which can be used ...
Insulin analogues with selective signaling properties and reduced mitogenicity
Case Western Reserve University
December 28, 2017 - N°20170369548

A two-chain insulin analogue contains aspartic acid at position b10 and penta-fluoro-phenylalanine at position b24, optionally histidine or glutamic acid at position a8, optionally additional substitutions or modifications at positions a13 and/or a14 and/or b28 and/or b29. The analogue may be an analogue of a mammalian insulin, such as human insulin, may optionally include (i) n-terminal deletion ...
1,3-substituted 2-amino-indole derivatives and analogues useful in the treatment or prevention of diabetes mellitus, obesity, ...
Takeda Pharmaceutical Company Limited
December 28, 2017 - N°20170369492

The present invention provides compounds of formula (i) and pharmaceutically acceptable salts thereof, wherein q, x4, x5, x6, x7, r1, r2, r3 and r8 are as defined in the specification, processes for the preparation of such compounds, pharmaceutical compositions containing them and the use of such compounds in therapy.
Uses of a pthrp analogue in reducing fracture risk
Radius Health, Inc.
December 28, 2017 - N°20170368148

Disclosed herein are pthrp or analogues thereof, such as abaloparatide, for preventing or reducing bone fractures in subjects in need thereof, as well as methods of using pthrp or analogues thereof to prevent or reduce bone fractures. Also disclosed are pthrp or analogues thereof, such as abaloparatide, for increasing bmd and/or tbs in subjects in need thereof, as well ...
Chemically and thermodynamically stable insulin analogues and improved methods for their production
Amidebio Llc
December 28, 2017 - N°20170368147

The subject matter of this invention is directed towards chemically and thermodynamically stable single-chain insulin (sci) analogues that are resistant to deamidation and fibrillation. The invention further discloses improved methods for the recombinant expression, purification and refolding of sci.
Processes for preparing dolutegravir and cabotegravir and analogues thereof
Lek Pharmaceuticals D.d.
December 28, 2017 - N°20170368040

The present invention relates to processes for preparing substances with antiviral activity, in particular the integrase inhibitors dolutegravir and cabotegravir and analogues thereof, as well as intermediates useful in the processes.
Compositions comprising sphingosine 1 phosphate (s1p) receptor modulators
Novartis Ag
December 28, 2017 - N°20170368001

The present invention relates to stable compositions comprising a sphingosine 1 phosphate (s1p) receptor modulator, suitable for use as a dosage form. The s1p receptor modulators are typically sphingosine analogues, such as 2-substituted 2-amino-propane-1,3-diol or 2-amino-propanol derivatives, e. G. A compound comprising a group of formula y.
Ingestion monitoring systems
Buddi Limited
December 28, 2017 - N°20170367639

An ingestion monitoring system (100) comprising: one or more acoustic transducers (102); an analogue to digital converter (208) arranged to convert electrical signals from the acoustic transducer to digital form; and a processor (210) arranged to process the digital signal to detect an ingestion event.
Loading